Compugen Appoints David Silberman As Its New CFO Effective August 15, 2024, Taking Over From Alberto Sessa Who Will Depart On The Same Day
Portfolio Pulse from Benzinga Newsdesk
Compugen has appointed David Silberman as its new CFO effective August 15, 2024, replacing Alberto Sessa. Silberman joins from Oramed Pharmaceuticals Inc., where he was CFO.
May 15, 2024 | 11:13 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
David Silberman, CFO of Oramed Pharmaceuticals, will leave the company to join Compugen as CFO effective August 15, 2024.
The departure of a CFO can create uncertainty and potential disruption, which may negatively impact investor sentiment towards Oramed Pharmaceuticals.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Compugen has appointed David Silberman as its new CFO effective August 15, 2024, replacing Alberto Sessa.
The appointment of a new CFO can bring fresh perspectives and strategies, potentially boosting investor confidence in Compugen.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100